Increasing access and availability to psychedelic-assisted psychotherapy means we are at the cusp of a revolution in the medical treatment of mental health issues. The current state of psychedelics within the fields of psychiatry and mental health will be presented, as well as the future for center based access to these medicines in Los Angeles in 2019 and beyond.
Rachel Hope was one of the first participants treated for chronic, treatment resistant PTSD in the MAPS-sponsored clinical trial that used MDMA-assisted psychotherapy. Rachel will speak on her message of personal life-saving transformation from decades of crippling trauma, failed therapies and prescribed drugs to a sustained, drug free recovery through MDMA-assisted therapy, ecstatic dance, and public activism. The three MDMA-assisted psychotherapy sessions set the stage for Rachel to be her own healer.